Skip to content
November 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Dialogue 2024 groepsfoto-dialoog VWS BZ - WHO
  • Breast Cancer Prevention and Lifestyle

Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Dialogue 2024

Jia Lissa September 27, 2026
In an era defined by geopolitical volatility, climate-induced health crises, and a lingering post-pandemic recovery, the synergy...
Read More Read more about Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Dialogue 2024
The Intersection of Advocacy and Survival: Angela Hernandez’s Journey Through Breast Cancer the-intersection-of-advocacy-and-survival-angela-hernandezs-journey-through-breast-cancer
  • Patient Advocacy and Support

The Intersection of Advocacy and Survival: Angela Hernandez’s Journey Through Breast Cancer

Siti Muinah September 27, 2026
Main Facts: A Life-Altering Diagnosis at the Threshold of 40 For many women, the age of 40...
Read More Read more about The Intersection of Advocacy and Survival: Angela Hernandez’s Journey Through Breast Cancer
Strengthening Global Health Architecture: A Strategic Dialogue Between Spain and the World Health Organization strengthening-global-health-architecture-a-strategic-dialogue-between-spain-and-the-world-health-organization-1
  • Global Breast Cancer Awareness

Strengthening Global Health Architecture: A Strategic Dialogue Between Spain and the World Health Organization

Evan Lee Salim September 27, 2026
Introduction: A Partnership for Global Resilience On April 23 and 24, 2024, the World Health Organization (WHO)...
Read More Read more about Strengthening Global Health Architecture: A Strategic Dialogue Between Spain and the World Health Organization
The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine the-genomic-frontier-how-the-broad-institute-is-rewriting-the-future-of-medicine-3
  • Genomics and Precision Medicine

The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine

Evan Lee Salim September 27, 2026
In the landscape of modern medicine, few institutions have exerted as profound an influence on the trajectory...
Read More Read more about The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine
The Scientific Imperative: ASHG Reaffirms Genetic Unity Amidst Rising Ideological Misinformation the-scientific-imperative-ashg-reaffirms-genetic-unity-amidst-rising-ideological-misinformation
  • Genomics and Precision Medicine

The Scientific Imperative: ASHG Reaffirms Genetic Unity Amidst Rising Ideological Misinformation

Sagoh September 27, 2026
ROCKVILLE, MD – In an era where the rapid advancement of genomic technology intersects with increasingly polarized...
Read More Read more about The Scientific Imperative: ASHG Reaffirms Genetic Unity Amidst Rising Ideological Misinformation
Reclaiming Intimacy: Navigating Sexual Health After a Breast Cancer Diagnosis reclaiming-intimacy-navigating-sexual-health-after-a-breast-cancer-diagnosis-1
  • Survivorship and Post-Treatment

Reclaiming Intimacy: Navigating Sexual Health After a Breast Cancer Diagnosis

Suro Senen September 27, 2026
This article was developed in collaboration with Gina Franco, MSN, NP-C, Dip ACLM, Director of the Center...
Read More Read more about Reclaiming Intimacy: Navigating Sexual Health After a Breast Cancer Diagnosis
Remigromig Shows Efficacy in DME, But Tolerability Concerns Loom for MSD’s Novel Therapy remigromig-shows-efficacy-in-dme-but-tolerability-concerns-loom-for-msds-novel-therapy
  • Medical Research and Clinical Trials

Remigromig Shows Efficacy in DME, But Tolerability Concerns Loom for MSD’s Novel Therapy

Jia Lissa September 27, 2026
The highly anticipated remigromig, MSD’s groundbreaking therapy for diabetic macular edema (DME), has demonstrated non-inferiority to the...
Read More Read more about Remigromig Shows Efficacy in DME, But Tolerability Concerns Loom for MSD’s Novel Therapy
Roche and Ionis Advance New Therapeutic Frontier in the Fight Against IgA Nephropathy roche-and-ionis-advance-new-therapeutic-frontier-in-the-fight-against-iga-nephropathy
  • Treatment Innovations

Roche and Ionis Advance New Therapeutic Frontier in the Fight Against IgA Nephropathy

Nana Wu September 27, 2026
By Jonathan Gardner | September 23, 2026 In a significant development for the nephrology community, Roche and...
Read More Read more about Roche and Ionis Advance New Therapeutic Frontier in the Fight Against IgA Nephropathy
A Landmark Victory: NHS England Approves Enhertu for HER2-Low Metastatic Breast Cancer a-landmark-victory-nhs-england-approves-enhertu-for-her2-low-metastatic-breast-cancer
  • Clinical Oncology Education

A Landmark Victory: NHS England Approves Enhertu for HER2-Low Metastatic Breast Cancer

Suro Senen September 27, 2026
In a decision hailed as a transformative moment for oncology care in the United Kingdom, the National...
Read More Read more about A Landmark Victory: NHS England Approves Enhertu for HER2-Low Metastatic Breast Cancer
The ROI of Intelligence: How AI Agents are Rewriting the Economics of Clinical Trials the-roi-of-intelligence-how-ai-agents-are-rewriting-the-economics-of-clinical-trials
  • Chemotherapy and Targeted Therapy

The ROI of Intelligence: How AI Agents are Rewriting the Economics of Clinical Trials

Basiran September 27, 2026
The pharmaceutical industry stands at a critical juncture. As clinical trial protocols grow exponentially in complexity—now capturing...
Read More Read more about The ROI of Intelligence: How AI Agents are Rewriting the Economics of Clinical Trials

Posts pagination

Previous 1 … 227 228 229 230 231 232 233 … 851 Next

Recent Posts

  • Landmark UK Approval Paves Way for First Disease-Modifying Therapy for Rare Mitochondrial Disorder
  • Beyond Philanthropy: Forging Powerful Corporate-Nonprofit Partnerships for Mutual Growth and Impact
  • The Evolution of Advocacy: Dr. Kelly Shanahan and the Changing Landscape of Metastatic Breast Cancer Research
  • Harnessing Intelligence: BCRF Symposium to Showcase AI-Driven Revolution in Breast Cancer Research
  • Dexcom Signals Sustained Growth: Financial Outlook Raised Following Strong Q3 Performance

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

landmark-uk-approval-paves-way-for-first-disease-modifying-therapy-for-rare-mitochondrial-disorder
  • Medical Research and Clinical Trials

Landmark UK Approval Paves Way for First Disease-Modifying Therapy for Rare Mitochondrial Disorder

Asep Darmawan November 2, 2026
beyond-philanthropy-forging-powerful-corporate-nonprofit-partnerships-for-mutual-growth-and-impact
  • Patient Advocacy and Support

Beyond Philanthropy: Forging Powerful Corporate-Nonprofit Partnerships for Mutual Growth and Impact

Laily UPN November 2, 2026
the-evolution-of-advocacy-dr-kelly-shanahan-and-the-changing-landscape-of-metastatic-breast-cancer-research
  • Patient Advocacy and Support

The Evolution of Advocacy: Dr. Kelly Shanahan and the Changing Landscape of Metastatic Breast Cancer Research

Nana Wu November 2, 2026
harnessing-intelligence-bcrf-symposium-to-showcase-ai-driven-revolution-in-breast-cancer-research
  • Patient Advocacy and Support

Harnessing Intelligence: BCRF Symposium to Showcase AI-Driven Revolution in Breast Cancer Research

Ali Ikhwan November 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.